The Bombay High Court ordered the deletion of false information following the circulation of fake videos featuring NSE's MD and CEO Ashishkumar Chauhan
Quant MF has managed to dominate the equity scheme performance charts in recent years, with its high-conviction bets working out well
Execution is likely to improve sharply in H2FY25 after some pickup in Q2FY25. Only 95 kilometres (km) of projects were awarded in Q1FY25 versus a full-year target of 5,000 kilometres
In a press release, the regulator stated that its junior employees were misinformed about automatic promotions and being underpaid despite having a cost-to-company of Rs 34 lakh per annum
Occupancy may improve by up to 5 per cent, with the average room rate growing at 7-8 per cent over three years
The benchmark Nifty's winning run continued, with the 50-share index managing to eke out just a 1.15-point gain on Tuesday to end at 25,280
Discount brokers may raise charges
Benchmarks sprint to new closing records amid rate-cut speculation
The industry continues to see consolidation and the top five will gain aggregate market share due to large capex. This could lead to more pricing power
Strategic reboots and fresh opportunities drive broker upgrades for the two L&T subsidiaries
But derivatives trading turnover thaws, rising as investors warm up to short-term bets
Sensex gaining streak now lengthiest since Sep '23; both indices at new highs
The move is part of the country's top bourse's plan to divest its non-core businesses
n three separate notifications, the regulator has restricted associations between its regulated entities and unregistered individuals
Factors contributing to the buying spree among Foreign Institutional Investors include stabilisation of the Indian rupee and positive sentiment regarding India's growth story
Over the past 45 years, the 30-share blue-chip index has skyrocketed nearly 700 times, a compound annual growth rate of 15% in local currency terms
India is a very underpenetrated aviation market, which means a strong growth outlook
In an advisory issued for investors, NSE and BSE specified that fraudulent actors are using both Indian and international phone numbers to orchestrate their schemes
The brokerage has estimated a 9 per cent earnings growth over FY24-26 for GSK Pharma
NMDC spent Rs 400 crore on capex in Q1 against the annual target of Rs 2,200 crore for FY25